EUVIMEDEUVIMED entdecken
Crossref

Simvastatin Targets PKM2 to Alter Metabolic Reprogramming in Hepatic Stellate Cells and Mitigate Liver Fibrosis

Ruoru Zhou, Ziqiang Xia, Xiangting Zhang, Xiao Wu, Kanglei Ying, Hong Pan, Huiya Ying, Jun Xu, Yuan Zeng, Weimin Cai, Yixiao Wang, Dandan Zhu und 2 weitere

The FASEB Journal · 2026

DOI: 10.1096/fj.202503580r ↗

Kurz gefasst

Fachartikel in der Zeitschrift The FASEB Journal, 2026. Verfasst von Ruoru Zhou und 13 weiteren Autor:innen. Beteiligte Einrichtung: Department of Gastroenterology, The First Affiliated Hospital of Wenzhou Medical University, Wenzhou, Zhejiang, China. Hauptthemen laut MEDLINE: Simvastatin, Hepatic Stellate Cells, Liver Cirrhosis, Carrier Proteins. Die Arbeit nennt 61 Literaturangaben. Gefördert von: MOST, NSFC, NSFC-Zhejiang Joint Fund.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Hepatic stellate cell (HSC) activation plays a crucial role in liver fibrosis progression, with glycolysis and glutaminolysis serving as key components of metabolic reprogramming to sustain HSC activation. Simvastatin (SV) has been shown to ameliorate liver fibrosis; however, its underlying mechanisms remain unclear. This study aimed to explore the protective effects of SV on liver fibrosis with a focus on metabolic regulation. A carbon tetrachloride (CCl 4 )‐induced liver fibrosis model was established in mice, and SV was administered via gavage. LX‐2 cells were used for in vitro mechanistic studies. Our findings demonstrated that SV effectively suppressed aerobic glycolysis and glutaminolysis in activated HSCs. Mechanistically, SV inhibited the PKM2/STAT3/c‐MYC pathway by targeting PKM2, leading to reduced c‐MYC expression. This downregulation of c‐MYC decreased ASCT2 expression, a key transporter in glutamine metabolism, thereby impairing glutamine utilization. These results provide new insights into the metabolic regulatory mechanisms of SV in liver fibrosis and lay the foundation for further exploration of its therapeutic potential in liver disease.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

SimvastatinHepatic Stellate CellsLiver CirrhosisCarrier ProteinsMembrane ProteinsThyroid HormonesAnimalsMiceMetabolic ReprogrammingGlycolysisHumansMaleMice, Inbred C57BLThyroid Hormone-Binding ProteinsCarbon TetrachlorideSTAT3 Transcription FactorAmino Acid Transport System ASCCell LineHydroxymethylglutaryl-CoA Reductase InhibitorsGlutamineProto-Oncogene Proteins c-mycPyruvate Kinase

Stichwörter der Autor:innen

glutaminolysisglycolysishepatic stellate cellsliver fibrosissimvastatin

Substanzen

SimvastatinPkm protein, mouseThyroid Hormone-Binding ProteinsCarbon TetrachlorideSTAT3 Transcription FactorAmino Acid Transport System ASCCarrier ProteinsMembrane ProteinsThyroid HormonesHydroxymethylglutaryl-CoA Reductase Inhibitors

Autor:innen und Institutionen

  • Department of Gastroenterology, The First Affiliated Hospital of Wenzhou Medical University, Wenzhou, Zhejiang, China.
  • Wenzhou Medical University, Wenzhou, Zhejiang, China.

ORCID-Profile: Fujun Yu

Förderung

  • MOST
  • NSFC
  • NSFC-Zhejiang Joint Fund
  • Natural Science Foundation of Zhejiang Province (ZJNSF)
  • Medical and Health Research Project of Zhejiang Province ()
  • Science and Technology Plan Project of Wenzhou Municipality ()
  • Ministry of Science and Technology of the People's Republic of China
  • National Natural Science Foundation of China

Zitieren

APA

Zhou, R., Xia, Z., Zhang, X., Wu, X., Ying, K., Pan, H., Ying, H., Xu, J., Zeng, Y., Cai, W., Wang, Y., Zhu, D., Miao, L., & Yu, F. (2026). Simvastatin Targets PKM2 to Alter Metabolic Reprogramming in Hepatic Stellate Cells and Mitigate Liver Fibrosis. The FASEB Journal. https://doi.org/10.1096/fj.202503580r

Vancouver

Zhou R, Xia Z, Zhang X, Wu X, Ying K, Pan H, et al. Simvastatin Targets PKM2 to Alter Metabolic Reprogramming in Hepatic Stellate Cells and Mitigate Liver Fibrosis. The FASEB Journal. 2026. doi:10.1096/fj.202503580r

BibTeX
@article{Zhou2026,
  author = {Zhou, Ruoru and Xia, Ziqiang and Zhang, Xiangting and Wu, Xiao and Ying, Kanglei and Pan, Hong and Ying, Huiya and Xu, Jun and Zeng, Yuan and Cai, Weimin and Wang, Yixiao and Zhu, Dandan and Miao, Lei and Yu, Fujun},
  title = {Simvastatin Targets PKM2 to Alter Metabolic Reprogramming in Hepatic Stellate Cells and Mitigate Liver Fibrosis},
  journal = {The FASEB Journal},
  year = {2026},
  doi = {10.1096/fj.202503580r}
}
Kostenlos starten →